Effect of Baseline HIV Disease Parameters on CD4+ T Cell Recovery After Antiretroviral Therapy Initiation in Kenyan Women (original) (raw)
Poor Initial CD4+ Recovery With Antiretroviral Therapy Prolongs Immune Depletion and Increases Risk for AIDS and Non-AIDS Diseases
David Krason
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
View PDFchevron_right
The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda
Francis Ssali
Aids Research and Therapy, 2009
View PDFchevron_right
THE RELATIONSHIP BETWEEN BASELINE CD4 T CELLS' LEVEL AND RECOVERY RATE AFTER INITIATION OF ART IN HIV/AIDS INFECTED AT HOSPITAL FOR TROPICAL DISEASES, VIETNAM
Asian Journal of Pharmaceutical and Clinical Research Journal
Asian Journal of Pharmaceutical and Clinical Research, 2020
View PDFchevron_right
Immune recovery among HIV-infected patients in northwestern Tanzania after 2 years of anti-retroviral therapy use: a retrospective cohort study
Bonaventura Mpondo, alex ernest
View PDFchevron_right
High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort
Harriet Mayanja-kizza
BMC Infectious Diseases, 2011
View PDFchevron_right
The Effect of HIV Treatment Interruption on Subsequent Immunological Response
Beverly Musick
American Journal of Epidemiology, 2023
View PDFchevron_right
Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course
Pierre Dellamonica
The Journal of antimicrobial chemotherapy, 2017
View PDFchevron_right
CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 YearsThe Swiss HIV Cohort Study
Milos Opravil
Archives of Internal Medicine, 2003
View PDFchevron_right
Low antigen-specific CD4 T-cell immune responses despite normal absolute CD4 counts after long-term antiretroviral therapy an African cohort
Rose Nabatanzi, Isaac Ssinabulya
Immunology Letters, 2014
View PDFchevron_right
Pattern of CD4 + T cell recovery and determinants of HIV infected individuals receiving highly active antiretroviral treatment in Mekelle Hospital, Tigray Northern Ethiopia; Retrospective study
Tsehaye Asmelash
View PDFchevron_right
CD4+ T-cell recovery after initiation of antiretroviral therapy in a resource-limited setting: A prospective cohort analysis
Barbara Mukasa
Antiviral Therapy, 2013
View PDFchevron_right
Immunological response among HIV/AIDS patients before and after ART therapy at
DERESSE DAKA
View PDFchevron_right
Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy
Martin Rickenbach
Clinical Infectious Diseases, 2005
View PDFchevron_right
Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/μL in HIV Type 1–Infected Individuals Receiving Potent Antiretroviral Therapy
Milos Opravil, Hansjakob Furrer
Clinical Infectious Diseases, 2005
View PDFchevron_right
Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on Antiretroviral Therapy (ART) in sub-Saharan Africa: Frequency and clinical significance
Fowzia Ibrahim
AIDS Research and Therapy, 2008
View PDFchevron_right
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
Edwina J Wright
New England Journal of Medicine, 2013
View PDFchevron_right
Immune activation while on potent antiretroviral therapy can predict subsequent CD4+ T-Cell increases through 15 years of treatment
Peter Hunt
View PDFchevron_right
Impact of age on CD4 recovery and viral suppression over time among adults living with HIV who initiated antiretroviral therapy in the African Cohort Study
Gwamaka Mwaisanga
AIDS Research and Therapy, 2020
View PDFchevron_right
Evidence of a Decrease in CD4 Recovery Once Back on Antiretroviral Therapy After Sequential ≥6 Weeks Antiretroviral Therapy Interruptions
Jay Kostman
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
View PDFchevron_right
Survival, CD4 T lymphocyte count recovery and immune reconstitution pattern during the first-line combination antiretroviral therapy in patients with HIV-1 infection in Mongolia
Tsogtsaikhan Sandag
PLOS ONE, 2021
View PDFchevron_right
Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database
Kathy Petoumenos, Reena Rajasuriar
PloS one, 2011
View PDFchevron_right
Higher CD27+CD8+ T cells percentages during suppressive antiretroviral therapy predict greater subsequent CD4+ T cell recovery in treated HIV infection
Gabriel Alejandro Lopz Ortiz
PloS one, 2013
View PDFchevron_right
Assessment of Pattern of CD4+ T-Cell Recovery Among Human Immunodeficiency Virus Patients After Initiation of Highly Active Antiretroviral Therapy at Arsi Negelle Health Center, Ethiopia: A Retrospective Cross-Sectional Study
Temesgen Bizuayehu
HIV/AIDS - Research and Palliative Care, 2020
View PDFchevron_right
Determinants of CD4 Immune Recovery Among Individuals on Antiretroviral Therapy in South Africa
Ngormbu Jusu Ballah, Gloria de Gita
2016
View PDFchevron_right
Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study
Bruno Brando
PLOS ONE, 2019
View PDFchevron_right